Haemair Overview

  • Founded
  • 2005
  • Status
  • Private
  • Employees
  • 9
  • Latest Deal Type
  • Grant
  • Latest Deal Amount
  • $1.81M
Latest Deal Amount
  • Investors
  • 4

Haemair General Information


Developer of a medical device and respiratory aids intended to be used for directly oxygenate blood to augment residual lung capacity and ultimately provide an alternative to lung transplant. The company's medical device and respiratory aids range from devices that support respiration for patients with deficient lungs via an easily reversible fully external device to a prosthetic device that may replace human lungs, enabling patients suffering from lung diseases to avail themselves a modern way to cure lung diseases effectively.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Other Industries
Other Healthcare Services
Primary Office
  • Room 403, ILS Phase 2
  • Swansea University Singleton Park
  • Swansea SA2 8PP
  • Wales, United Kingdom
+44 01792 000000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Haemair Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Grant 01-Apr-2015 $1.81M 00000 Completed
2. Later Stage VC 10-Aug-2010 00000 00000 00.000 Completed Generating Revenue
1. Grant $2.56M Completed Generating Revenue
To view Haemair’s complete valuation and funding history, request access »

Haemair Cap Table

Stock # of Shares
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary 1 00,000 00.000000 00.00 00.00 00 00.00 00.000
To view Haemair’s complete cap table history, request access »

Haemair Board Members (5)

Name Representing Role Since
David Llewellyn Haemair Board Member 000 0000
Judith Johns Haemair Board Member 000 0000
Leon Goldberg Haemair Board Member 000 0000
Ronald Knight Haemair Board Member 000 0000
William Johns Haemair Board Member 000 0000
To view Haemair’s complete board members history, request access »

Haemair Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Haemair Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Innovate UK Government 000 0000 000000 0
Development Bank of Wales Venture Capital Minority 000 0000 000000 0
National Health Service Government 000 0000 000000 0
Welsh Government Government 000 0000 000000 0
To view Haemair’s complete investors history, request access »